Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Toxicol Mech Methods. 2022 Nov 29;33(5):378–387. doi: 10.1080/15376516.2022.2150591

Table 3.

Correlation Coefficient for Strength of Linear Relationship and Breusch-Pagan test for Homoscedasticity

Health Outcome R Strength R Strength r Strength Breusch-Pagan p-value
AA .42 moderate .61 strong .31 weak
A .42 moderate .27 weak −.20 weak
AK .25 weak .38 weak .16 weak
AsA .40 moderate .55 moderate .45 moderate .44 <.01 .16
B .07 weak .34 weak .35 weak
C .66 moderate .54 moderate .07 weak
CK .45 moderate .57 moderate .40 moderate .39 .05 .17
Cr −.18 weak −.04 weak −.47 moderate
DB .12 weak .29 weak .30 weak
G .26 weak .27 weak −.10 weak
SD .63 moderate .62 moderate .41 moderate .24 .16 .71
TB −.30 weak −.10 weak .28 weak
TP −.33 weak −.38 weak −.41 moderate
Tg −.24 weak −.30 weak −.33 weak
U .07 weak .10 weak .23 weak

Note: Parameters measured included alanine aminotransferase (AA), albumin (A), alkaline phosphatase (Ak), aspartate aminotransferase (AsA), bile salts/acids (B), cholesterol (C), creatinine kinase (CK), direct bilirubin (DB), sorbitol dehydrogenase (SD), total protein (TP), and urea nitrogen (U). Abbreviations indicate the parameter in which a difference (p<.001) was identified and the dose levels (1, 2 and/or 3, shown as superscript) at which a difference occurred.